Related Experiment Video

Updated: Aug 9, 2026

Induction of Petite Colonies in Candida glabrate via Rose Bengal-Mediated Photodynamic Therapy
09:06

Induction of Petite Colonies in Candida glabrate via Rose Bengal-Mediated Photodynamic Therapy

Published on: March 29, 2024

Targeted short-term fluconazole prophylaxis among very low birth weight and extremely low birth weight infants

Smart Uko1, Lamia M Soghier, Melissa Vega

  • 1Division of Neonatology, Department of Pediatrics, Albert Einstein College of Medicine, Children's Hospital at Montefiore, Bronx, New York, USA.

Pediatrics
|April 6, 2006
PubMed

Insights

Targeted fluconazole prophylaxis significantly reduced invasive fungal infections (IFI) in very low birth weight (VLBW) and extremely low birth weight (ELBW) infants. This intervention proved cost-effective with no increase in mortality rates.

Area of Science:

  • Neonatal Medicine
  • Infectious Diseases
  • Pharmacology

Background:

  • Invasive fungal infections (IFI) pose a significant threat to vulnerable VLBW and ELBW infants.
  • Late-onset IFI can lead to increased morbidity and mortality in this population.
  • Prophylactic strategies are crucial for improving outcomes in high-risk neonates.

Purpose of the Study:

  • To evaluate the efficacy of targeted short-term fluconazole prophylaxis in preventing late-onset IFI in VLBW and ELBW infants.
  • To assess the impact of fluconazole prophylaxis on mortality rates, potential toxicities, and healthcare costs.
  • To determine the cost-effectiveness of this prophylactic approach.

Main Methods:

  • An observational study comparing two epochs: a control period and a period with routine targeted fluconazole prophylaxis.
  • Infants included had a birth weight <1500 g or gestational age <32 weeks.
  • Targeted prophylaxis involved administering fluconazole (3 mg/kg) to infants requiring broad-spectrum antibiotics for over 3 days.

Main Results:

  • IFI rates decreased significantly from 6.3% in the control group to 1.1% in the fluconazole prophylaxis group (OR 0.166).
  • Logistic regression confirmed fluconazole prophylaxis was associated with lower IFI rates.
  • No significant change in late mortality rates was observed; the intervention was cost-effective with an NNT of 10 to prevent one IFI.

Conclusions:

  • Targeted short-course fluconazole prophylaxis demonstrates efficacy in reducing IFI among VLBW and ELBW infants.
  • The intervention is considered cost-effective and does not appear to increase mortality.
  • This strategy offers a promising approach to managing fungal infections in high-risk neonates.
Abstract

More Related Videos

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians06:49

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians

Published on: March 14, 2014

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...